Navigation Links
Prostate Cancer Risk and Smoking
Date:6/30/2011

NEW YORK, June 30, 2011 /PRNewswire/ -- According to a recent study published in The Journal of the American Medical Association (JAMA), men with prostate cancer who smoke have increased prostate cancer-specific mortality compared to non-smokers with prostate cancer.  Smokers were also found to have a 61% increased risk of cancer recurrence after treatment. Interestingly, these increased mortality and recurrence rates were not seen in men who had quit smoking for at least 10 years. These men had similar risk profiles to those who never smoked.

(Photo:  http://photos.prnewswire.com/prnh/20110630/NY28444 )

In addition to what it tells us about the effects of smoking, this study also presents an important element of prevention into the general discussion of prostate cancer. While the major risk factors for the disease; age, race and family history, are well known, these factors are non-modifiable. Most doctors, therefore, recommend annual PSA screening in order to diagnose cancer as early as possible, especially for those who have high risk profiles. Unlike age, race and family history, however, smoking is a modifiable risk. According to this recent study, patients with prostate cancer who quit smoking for ten years will bring themselves back down to the risk category of those who never smoked at all.

Coincidentally, the FDA announced this week that new health warnings must be displayed on all cigarette packages and advertisements in the United States beginning no later than September 2012.  The new, larger warning labels show pictures of the effects smoking has on a person's health in graphic detail. With the ever-increasing medical evidence showing the harmful effects of smoking, there has never been a better time to quit.

For Dr. David Samadi, Vice Chairman, Department of Urology, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, the new information about smoking and prostate cancer makes all the difference. "Prostate cancer is a deadly disease, but it is not a death sentence. Men need to use all of the resources available to keep their risk as low as possible." He explained further, "Quitting smoking, as this study has shown, reduces your risk of dying from prostate cancer and of recurring once you've had treatment. And even if you've never smoked, you still need to get PSA testing annually over the age of 50 to stay in control of your health. If you have a family history of the disease, or of African American ancestry, you need to consider getting earlier PSA testing at 40."  

For those who are, unfortunately, diagnosed with prostate cancer, Dr. Samadi performs advanced, minimally-invasive robotic prostate surgery. Using his own SMART (Samadi Modified Advanced Robotic Technique) surgery, Dr. Samadi gives his patients excellent sexual and urinary quality of life after the prostate cancer treatment procedure with minimal risk of cancer recurrence. "The key is to lower your risk before diagnosis, and get PSA tested to ensure an early diagnosis. If you need to be treated, however, you'll want to choose a procedure that will eliminate the cancer while at the same time preserve your quality of life for years to come."

Dr. Samadi discusses men's health, prostate cancer prevention and prostate cancer risks associated with smoking on Fox News:

Smoking Linked to Increased Prostate Cancer Mortality‎

http://www.youtube.com/watch?v=Tzbfcp7dTsg

Prostate Cancer Prevention News - www.roboticoncology.com

http://www.youtube.com/watch?v=Pew6M7hckNY

Related Links: Smart-Surgery.com


'/>"/>
SOURCE RoboticOncology.com
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
2. Patented URINOZINC® Prostate Formula Now Available at GNC Stores
3. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
4. Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials
5. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
6. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
7. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
8. Reportlinker Adds Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer
9. Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies
10. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
11. New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... ... affiliations and de novo development, today announced Cumberland Skin Surgery and Dermatology ... Surgery and Dermatology, with offices in both Hermitage and Lebanon, Tennessee, provides comprehensive ...
(Date:8/16/2017)... ... 2017 , ... Paul Vitenas, MD, FACS , is honored to announce ... list identifies the nation’s top physicians, in a variety of specialties. This marks the ... of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of ... every reprocessing cycle, both between patient procedures and before storage, is a requisite ... as important to the prevention of disease transmission and nosocomial infection as cleaning ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... $5.99, eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery ... of God's love, and all the many ways God shows love to those ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... an opportunity for men and women to train as hospice volunteers. Volunteers provide ... life-limiting illness. For over 30 years, the agency has trained volunteers to be ...
Breaking Medicine News(10 mins):